• Busca personas
• Intranet

Farmacología integrada y neurociencia de sistemas Rafael de la Torre

Publicaciones 2025 (18)

• Fresán U^*, Boronat A, Zazpe I, Bes-Rastrollo M, Buekers J, de la Torre R, Chevance G^*. Validation of REFRESH: a dietary screener for Rapid Evaluation FoR Environmentally Sustainable and Healthy diets. J Nutr 2025: (en Premsa).
  Cites:0
  Cites:0
• Forcano L, Soldevila N, Boronat A, Sánchez-Benavides G, Puig-Pijoan A, Lorenzo T, Aldea-Perona A, Suarez-Calvet M, Cuenca A, Gispert JD, Gomis-González M, Minguillón C, Diaz-Pellicer P, Fauria K, Piera I, Langohr K, Dierssen M, Pizarro N, Mur-Gimeno E, Grau-Rivera O, Molinuevo JL, de la Torre R^*, PENSA working group. A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ε4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study). JPAD-J PREV ALZHEIM 2025: (en Premsa).
• Barrera M, Korchevaya E, Kossatz de Mello E, Veza E, Pujadas-Bastardes M, Alechaga E, Nebot P, Pozo O, de la Torre R, Pizarro N, Robledo P^*. Synbiotic intervention reverses alcohol drinking-induced cognitive deficits in adolescent male mice by modulating the microbiota-gut-brain axis. Gut Microbes . 2025; 17(1): 2551104.
  Cites:0
  Cites:0
• Perez M, Armengol E, Del Casale A, Campadelli I, Aldea-Perona A, Pérez M, Rodriguez-Palmero M, Espadaler J, Huedo P^*. Lactobacillus gasseri CECT 30648 shows probiotic characteristics and colonizes the vagina of healthy women after oral administration. Microbiol Spectr . 2025; 13(9): e0021125.
• Lorenzo T^*, Ngandu T, Lehtisalo J, Antikainen R, Gispert JD, Kemppainen N, Laatikainen T, Lindström J, Rinne J, Soininen H, Strandberg T, de la Torre R, Tuomilehto J, Solomon A, Kivipelto M. Associations of Prediabetes, Diabetes and Glucose-Related Markers With Cognition and Neuroimaging in a 2-Year Multidomain Lifestyle Randomised Controlled Trial. Diabetes Metab Res Rev . 2025; 41(5): e70053.
  Cites:0
  Cites:0
• Palmqvist S^*, Warmenhoven N, Anastasi F, Pilotto A, Janelidze S, Tideman P, Stomrud E, Mattsson-Carlgren N, Smith R, Ossenkoppele R, Tan K, Dittrich A, Skoog I, Zetterberg H, Quaresima V, Tolassi C, Höglund K, Brugnoni D, Puig-Pijoan A, Fernández A, Contador J, Padovani A, Monane M, Verghese PB, Braunstein JB, Kern S, Blennow K, Ashton NJ, Suarez-Calvet M, Hansson O^*. Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform. Nat Med 2025; 31(6): 2036-2043.
  Cites:2
  Cites:2
• Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In 't Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Houtkamp IM, Koel-Simmerlink M, Verberk IMW, Gaetani L, Toja A, Wojdala AL, Fortea J, Pijnenburg Y, Lemstra A, van der Flier WM, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, Gonzalez-Escalante A, Contador J, Suarez-Calvet M, Fernández A, Puig-Pijoan A, Ortiz-Romero P, Jiménez-Moyano E, Minguillón C, Del Campo M, Teunissen C^*. Diagnostic performance of plasma A?42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study. Alzheimers Dement 2025; 21(6): e14573.
• Hladun O, Papaseit E^*, Poyatos L, Martin S, Pérez-Acevedo AP, Barriocanal ÁM, Bustos-Cardona T, Malumbres S, de la Torre R, Langohr K, Farré M, Pérez-Mañá C^*. No significant gender differences in driving-related skills following alcohol mixed with energy drinks during an experimental binge-drinking episode. Front Pharmacol 2025; 16: 1581229 (Acceptat).
  Cites:0
  Cites:0
• Flores-López M, Herrera-Imbroda J, Requena-Ocaña N, García-Marchena N, Araos P, Verheul-Campos J, Ruiz JJ, Pastor A, de la Torre R, Bordallo A, Pavón-Morón FJ^*, Rodríguez de Fonseca F^*, Serrano A. Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis. Prog Neuro-Psychopharmacol Biol Psychiatr 2025; 138: 111350.
  Cites:0
  Cites:0
• Soldevila N, Ayala A, Barbera M, Lehtisalo J, Forcano L, Diaz-Ponce A, Zwan M, van der Flier WM, Ngandu T, Kivipelto M, Solomon A, de la Torre R^*. Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions. Alzheimers Res. Ther. 2025; 17(1): 61.
  Cites:2
  Cites:2
• Caballero I, Mbouamboua Y, Weise S, López-Gálvez R, Couralet M, Fleurot I, Pons N, Barrera M, Quílez-Playán N, Keller M, Klymiuk N, Robledo P, Hummel T, Barbry P, Chamero P^*. Cystic fibrosis alters the structure of the olfactory epithelium and the expression of olfactory receptors affecting odor perception. Sci Adv 2025; 11(9): eads1568.
  Cites:0
  Cites:0
• Anastasi F, Fernández A, Ashton NJ, Ortiz-Romero P, Torres-Torronteras J, Gonzalez-Escalante A, Milà M, Contador J, García-Escobar G, Manero RM, Navalpotro I, Jiménez-Moyano E, Sahajan A, Hao Q, Zhang B, Jeromin A, Le Bastard N, Nadal A, Mousavi T, Kollmorgen G, Carboni M, Grau-Rivera O, Zetterberg H, Del Campo M, Blennow K, Puig-Pijoan A^*, Suarez-Calvet M^*. A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic. Alzheimers Dement 2025; 21(2): e14609.
  Cites:1
  Cites:1
• Naranjo L, Sarto J, Nos C, Alcolea D, Rodríguez-Baz I, Navalpotro I, Fernández A, Bertran-Recasens B, Erro ME, Pelayo-Negro AL, Esteve C, Fernandez S, Massot A, Boltes A, Torrents A, Guanyabens N, Palomino-García A, Egri N, Lladó A, Balasa M, Romera MA, Antón MDC, Couso RS, Sánchez Valle R^*, Ruiz-García R, Spanish sCJD Study Group. Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease. J Neurol 2025; 272(3): 198.
  Cites:0
  Cites:0
• Zeng H^*, Schagen SB, Hendriks LEL, Sánchez-Benavides G, Jaspers JPM, Manero RM, Lievens Y, Murcia M, Kuenen M, Rico-Oses M, Albers EAC, Samper P, Houben R, De Ruiter, Dieleman EMT, López-Guerra JL, De Jaeger, Couñago F, Lambrecht M, Calvo-Crespo P, Belderbos JSA, De Ruysscher, Rodriguez de Dios N. Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials. Lung Cancer 2025; 199: 108036 .
  Cites:2
  Cites:2
• Ayala A^*, Serra L, Rodríguez-Arjona D, Benavides F, Utzet M. Understanding Return to Work After a Cancer-Related Sickness Absence. Perceptions of Barriers and Facilitators Among all Relevant Stakeholders. Psycho-Oncol 2025; 33(12): e70036.
  Cites:0
  Cites:0
• Manzano-Nuñez R^*, Gomez DA, Toledo C, Pérez M, Matilla IL, Prats C, Perez-Lopez EM, Pardo H, Diaz-Pellicer P, de la Torre R, Aldea-Perona A. Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics. Clin Neuropharmacol 2025; 48(1): 13-19.
  Cites:2
  Cites:2
• Fresán U^*, López-Moreno M, Fàbregues S, Bernard P, Boronat A, Araújo-Soares V, König LM, Buekers J, Chevance G. Feasibility and potential effect of a pilot blended digital behavior change intervention promoting sustainable diets over a year. Sci Rep 2025; 15(1): 2052.
  Cites:1
  Cites:1
• Gonzáles JA, Barrera M, Kossatz de Mello E, Veza E, de la Torre R, Busquets A^*, Robledo P^*, Pizarro N^*. Microbiota and social behavior alterations in a mouse model of down syndrome: Modulation by a synbiotic treatment. Prog Neuro-Psychopharmacol Biol Psychiatr 2025; 136: 111200.
  Cites:0
  Cites:0